Literature DB >> 21847731

PET-CT in children: where is it appropriate?

Sue C Kaste1.   

Abstract

The use of PET/PET-CT is a rapidly growing area of imaging and research in the care of children. Until recently, diagnostic imaging methods have provided either anatomical or functional assessment. The development of fused imaging modalities, such as PET-CT or PET-MRI, now provides the opportunity for simultaneously providing both anatomical and functional or physiological assessment. This review will discuss current established uses of PET-CT, possible uses and potential research investigations in the use of this modality in the pediatric population. The focus of this paper will be its use in children being treated for non-central nervous system and non-cardiac disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21847731      PMCID: PMC4698349          DOI: 10.1007/s00247-011-2096-1

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  53 in total

1.  Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry.

Authors:  Joanna Begent; Neil J Sebire; Gill Levitt; Penelope Brock; Kathy Pritchard Jones; Peter Ell; Isky Gordon; John Anderson
Journal:  Eur J Cancer       Date:  2010-11-10       Impact factor: 9.162

2.  PET-CT in pediatric Langerhans cell histiocytosis.

Authors:  Sue C Kaste; Carlos Rodriguez-Galindo; Mary E McCarville; Barry L Shulkin
Journal:  Pediatr Radiol       Date:  2007-05-22

Review 3.  18F-PET-CT in extracranial paediatric oncology: when and for whom is it useful?

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2008-06

4.  Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines.

Authors:  Michael J Gelfand; Marguerite T Parisi; S Ted Treves
Journal:  J Nucl Med       Date:  2011-01-13       Impact factor: 10.057

5.  Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn's disease.

Authors:  Anis Ahmadi; Qin Li; Keith Muller; Dennis Collins; John F Valentine; Walter Drane; Steven Polyak
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

6.  Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience.

Authors:  L Federici; C Blondet; A Imperiale; J Sibilia; J-L Pasquali; F Pflumio; B Goichot; G Blaison; J-C Weber; D Christmann; A Constantinesco; E Andrès
Journal:  Int J Clin Pract       Date:  2008-05-08       Impact factor: 2.503

7.  F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.

Authors:  C P Bleeker-Rovers; S J H Bredie; J W M van der Meer; F H M Corstens; W J G Oyen
Journal:  Neth J Med       Date:  2003-10       Impact factor: 1.422

8.  Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.

Authors:  B L Shulkin; R J Hutchinson; V P Castle; G A Yanik; B Shapiro; J C Sisson
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

9.  Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?

Authors:  Laurent Arnaud; Julien Haroche; Zoulikha Malek; Frédérique Archambaud; Laetitia Gambotti; Gilles Grimon; Aurélie Kas; Nathalie Costedoat-Chalumeau; Patrice Cacoub; Dan Toledano; Philippe Cluzel; Jean-Charles Piette; Zahir Amoura
Journal:  Arthritis Rheum       Date:  2009-04

10.  18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma.

Authors:  Colleen M Costelloe; Homer A Macapinlac; John E Madewell; Nancy E Fitzgerald; Osama R Mawlawi; Eric M Rohren; A Kevin Raymond; Valerae O Lewis; Peter M Anderson; Roland L Bassett; Robyn K Harrell; Edith M Marom
Journal:  J Nucl Med       Date:  2009-03       Impact factor: 10.057

View more
  8 in total

1.  Quantitative analysis of image metrics for reduced and standard dose pediatric 18F-FDG PET/MRI examinations.

Authors:  Pietro Zucchetta; Marco Branchini; Alessandra Zorz; Valentina Bodanza; Diego Cecchin; Marta Paiusco; Franco Bui
Journal:  Br J Radiol       Date:  2019-01-23       Impact factor: 3.039

2.  Pediatric nuclear medicine and pediatric radiology: modalities, image quality, dosimetry and correlative imaging: new strategies.

Authors:  Isabel Roca-Bielsa; Marina Vlajković
Journal:  Pediatr Radiol       Date:  2013-03-24

Review 3.  2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.

Authors:  John Freebody; Eva A Wegner; Monica A Rossleigh
Journal:  World J Radiol       Date:  2014-10-28

4.  ¹⁸F-FDG PET/CT in the diagnosis of occult bacterial infections in children.

Authors:  Teresa del Rosal; Walter A Goycochea; Ana Méndez-Echevarría; Marta García-Fernández de Villalta; Fernando Baquero-Artigao; Mónica Coronado; Maria Dolores Marín; Luis Albajara
Journal:  Eur J Pediatr       Date:  2013-03-12       Impact factor: 3.183

Review 5.  Dosage optimization in positron emission tomography: state-of-the-art methods and future prospects.

Authors:  Nicolas A Karakatsanis; Eleni Fokou; Charalampos Tsoumpas
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

6.  Comparison of hyperpolarized 13 C and non-hyperpolarized deuterium MRI approaches for imaging cerebral glucose metabolism at 4.7 T.

Authors:  Cornelius von Morze; John A Engelbach; Tyler Blazey; James D Quirk; Galen D Reed; Joseph E Ippolito; Joel R Garbow
Journal:  Magn Reson Med       Date:  2020-11-28       Impact factor: 4.668

Review 7.  Non-odontogenic tumors of the facial bones in children and adolescents: role of multiparametric imaging.

Authors:  Minerva Becker; Salvatore Stefanelli; Anne-Laure Rougemont; Pierre Alexandre Poletti; Laura Merlini
Journal:  Neuroradiology       Date:  2017-03-13       Impact factor: 2.804

Review 8.  Masses of developmental and genetic origin affecting the paediatric craniofacial skeleton.

Authors:  Salvatore Stefanelli; Pravin Mundada; Anne-Laure Rougemont; Vincent Lenoir; Paolo Scolozzi; Laura Merlini; Minerva Becker
Journal:  Insights Imaging       Date:  2018-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.